FDA investigators audited the Cipla - Vasco Da Gama, India facility and issued 3 inspectional observations (via FDA 483) on 17 Feb 2011.
Product details
- Category: Human Drugs
- Number of Observations: 3
- Inspection end: 17 Feb 2011
- Location: Vasco Da Gama, India
- FEI: 3004081307
